Prothelia
Prothelia
prothelia.com

Locations

Milford, MA, USA · Boston, MA, USA · West Street / River Street, Boston, MA, USA

industry

Biotechnology

Size

1 - 10 employees

Stage

Other

founded in

2008

Prothelia is developing recombinant human laminin-111 (RHLAM-111) for treatment of Congenital Muscular Dystrophy Type 1A. This form of muscular dystrophy is also referred to as MDC1A, Merosin Deficiency, or LAMA2 Deficiency.

Something looks off?
Open jobs at Prothelia
This company does not have jobs relevant to this job board at this time.
To view all their jobs, visit their website.